Showing results (1831-1840 of 2,434) with videos related to

Sort By:
Pageof 244
Acta Oncologica (Stockholm, Sweden)|October 10, 2023
Clinical outcomes of ALK+ non-small cell lung cancer in DenmarkKarin Holmskov Hansen, Jakob Sidenius Johansen, Edyta Maria Urbanska, et al.
Oncotarget|September 18, 2018
Circulating tumor DNA as a marker of treatment response in BRAF V600E mutated non-melanoma solid tumorsLise Barlebo Ahlborn, Ida Viller Tuxen, Florent Mouliere, et al.
Blood|March 29, 2012
KAP1 regulates gene networks controlling mouse B-lymphoid cell differentiation and functionFrancesca R Santoni de Sio, Joanna Massacand, Isabelle Barde, et al.
BMC Cancer|February 12, 2011
The level of claudin-7 is reduced as an early event in colorectal carcinogenesisJette Bornholdt, Stine Friis, Sine Godiksen, et al.
Frontiers in Plant Science|September 27, 2019
Targeted Proteomics Allows Quantification of Ethylene Receptors and Reveals SlETR3 Accumulation in Never-Ripe TomatoesYi Chen, Valérie Rofidal, Sonia Hem, et al.
Translational Lung Cancer Research|April 18, 2025
Targeting of arachidonic acid-modulated autophagy to enhance the sensitivity of ROS1 + or ALK + non-small cell lung cancer to crizotinib therapyHui Jie, Hongjin Lai, Zihuai Wang, et al.
Acta Oncologica (Stockholm, Sweden)|August 19, 2017
Oligometastatic cancer: stereotactic ablative radiotherapy for patients affected by isolated body metastasisAndrea Lancia, Gianluca Ingrosso, Alessandra Carosi, et al.
Journal of Hematology & Oncology|December 2, 2016
Inhibition of bromodomain and extra-terminal (BET) proteins increases NKG2D ligand MICA expression and sensitivity to NK cell-mediated cytotoxicity in multiple myeloma cells: role of cMYC-IRF4-miR-125b interplayMaria Pia Abruzzese, Maria Teresa Bilotta, Cinzia Fionda, et al.
American Journal of Human Genetics|January 6, 2015
Biased allelic expression in human primary fibroblast single cellsChristelle Borel, Pedro G Ferreira, Federico Santoni, et al.
Targeted Oncology|December 11, 2021
Concomitant Proton Pump Inhibitors and Outcome of Patients Treated with Nivolumab Alone or Plus Ipilimumab for Advanced Renal Cell CarcinomaVeronica Mollica, Matteo Santoni, Marc R Matrana, et al.
Pageof 244